Första AP-fonden’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.1M | Buy |
21,100
+300
| +1% | +$158K | 0.07% | 231 |
|
|
2025
Q1 | $13.2M | Sell |
20,800
-1,300
| -6% | -$824K | 0.1% | 179 |
|
|
2024
Q4 | $15.7M | Sell |
22,100
-2,400
| -10% | -$1.71M | 0.11% | 161 |
|
|
2024
Q3 | $25.8M | Buy |
24,500
+2,200
| +10% | +$2.31M | 0.2% | 95 |
|
|
2024
Q2 | $23.4M | Sell |
22,300
-600
| -3% | -$631K | 0.21% | 89 |
|
|
2024
Q1 | $22M | Buy |
22,900
+2,900
| +15% | +$2.79M | 0.19% | 109 |
|
|
2023
Q4 | $17.6M | Sell |
20,000
-500
| -2% | -$439K | 0.18% | 114 |
|
|
2023
Q3 | $16.9M | Buy |
20,500
+200
| +1% | +$165K | 0.19% | 103 |
|
|
2023
Q2 | $14.6M | Sell |
20,300
-200
| -1% | -$144K | 0.16% | 133 |
|
|
2023
Q1 | $16.8M | Sell |
20,500
-4,700
| -19% | -$3.86M | 0.2% | 103 |
|
|
2022
Q4 | $18.2M | Sell |
25,200
-2,600
| -9% | -$1.88M | 0.21% | 105 |
|
|
2022
Q3 | $19.2M | Sell |
27,800
-400
| -1% | -$276K | 0.23% | 95 |
|
|
2022
Q2 | $16.7M | Sell |
28,200
-500
| -2% | -$296K | 0.22% | 101 |
|
|
2022
Q1 | $20M | Sell |
28,700
-2,200
| -7% | -$1.54M | 0.23% | 85 |
|
|
2021
Q4 | $19.5M | Buy |
30,900
+1,000
| +3% | +$632K | 0.2% | 100 |
|
|
2021
Q3 | $18.1M | Buy |
29,900
+1,800
| +6% | +$1.09M | 0.21% | 99 |
|
|
2021
Q2 | $15.7M | Buy |
28,100
+2,300
| +9% | +$1.28M | 0.18% | 117 |
|
|
2021
Q1 | $12.2M | Buy |
25,800
+4,600
| +22% | +$2.18M | 0.17% | 134 |
|
|
2020
Q4 | $10.2M | Buy |
21,200
+1,200
| +6% | +$580K | 0.15% | 147 |
|
|
2020
Q3 | $11.2M | Buy |
20,000
+6,400
| +47% | +$3.58M | 0.23% | 87 |
|
|
2020
Q2 | $8.48M | Buy |
13,600
+4,400
| +48% | +$2.74M | 0.22% | 107 |
|
|
2020
Q1 | $4.49M | Buy |
+9,200
| New | +$4.49M | 0.16% | 169 |
|